Entering text into the input field will update the search result below

ROTY Cliff Notes To Start 2022

Dec. 30, 2021 5:18 PM ET5 Comments
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

-Biotech investing was hell for me when I started in 2008, learning all my lessons the hard way.

-Thankful to have achieved a measure of success and consistency, in 2018 I decided to start the kind of service/resource I wish I'd had when starting out

-We are currently 725 members, an eclectic mix of industry veterans, experienced personal & institutional investors, and novices who enjoy sharing our thoughts together in Chat and bouncing ideas off each other

-My strategy is built around principle of ¨accelerating clinical momentum¨, and my goal is to keep improving & adding value to the best of my ability

-Main Portfolio (ROTY), focuses on accelerating clinical momentum over the next 12 months and has delivered roughly 4x return of benchmarks (XBI/IBB)

-Core Biotech (LT) focuses on accelerating clinical momentum over the next 3 to 5 years and is a lower maintenance strategy, very well diversified across a variety of modalities and disease areas

-Transparency is of utmost importance to us (highlight both winners and losers, trades occur at day's closing price)

-Premium services/Tools are meant to be tried out, only sticking with those that add value for you. 2 Week Trial should be sufficient to kick the tires


Join 700+ biotech investors and traders in the ROTY Community!

  • Participate in a Live Chat where members generously share due diligence, conviction picks and genuinely wish to see each other profit.
  • Get access to JF's high conviction ideas and monthly updates on our market-beating model account (+284% versus +77% for IBB and +89% for XBI since inception)
  • Try out other features intended to help you succeed, such as Cheat Sheet, Weekly Recap, 5 Minute Portfolio Rundown and much more.
  • Trade to Live, NOT Live to Trade philosophy (low maintenance, follow our thesis and make changes to positions only as merited)
  • ¨Teach a man to fish¨ approach (follow my thought process, learn from both winners and losers together)

Check out recent reviews of the service here.


Additional disclosure: Disclaimer: Commentary presented is NOT individualized investment advice. Opinions offered here are NOT personalized recommendations. Readers are expected to do their own due diligence or consult an investment professional if needed prior to making trades. Strategies discussed should not be mistaken for recommendations, and past performance may not be indicative of future results. Although I do my best to present factual research, I do not in any way guarantee the accuracy of the information I post. I reserve the right to make investment decisions on behalf of myself and affiliates regarding any security without notification except where it is required by law. Keep in mind that any opinion or position disclosed on this platform is subject to change at any moment as the thesis evolves. Investing in common stock can result in partial or total loss of capital. In other words, readers are expected to form their own trading plan, do their own research and take responsibility for their own actions. If they are not able or willing to do so, better to buy index funds or find a thoroughly vetted fee-only financial advisor to handle your account.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.